Gadolinium Deposition Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-05-16
Clinical Trial Update: DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure [EARLY_Phase 1]
An early-phase trial evaluating DTPA chelation for symptoms in gadolinium deposition disease has been withdrawn.